Literature DB >> 11022049

Differential contributions of NADPH-cytochrome P450 oxidoreductase FAD binding site residues to flavin binding and catalysis.

A L Shen1, C B Kasper.   

Abstract

Transfer of reducing equivalents from NADPH to the cytochromes P450 is mediated by NADPH-cytochrome P450 oxidoreductase, which contains stoichiometric amounts of tightly bound FMN and FAD. Hydrogen bonding and van der Waals interactions between FAD and amino acid residues in the FAD binding site of the reductase serve to regulate both flavin binding and reactivity. The precise orientation of key residues (Arg(454), Tyr(456), Cys(472), Gly(488), Thr(491), and Trp(677)) has been defined by x-ray crystallography (Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S., Kim, J.-J. P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8411-8416). The current study examines the relative contributions of these residues to FAD binding and catalysis by site-directed mutagenesis and kinetic analysis. Mutation of either Tyr(456), which makes van der Waals contact with the FAD isoalloxazine ring and also hydrogen-bonds to the ribityl 4'-hydroxyl, or Arg(454), which bonds to the FAD pyrophosphate, decreases the affinity for FAD 8000- and 25,000-fold, respectively, with corresponding decreases in cytochrome c reductase activity. In contrast, substitution of Thr(491), which also interacts with the pyrophosphate grouping, had a relatively modest effect on both FAD binding (100-fold decrease) and catalytic activity (2-fold decrease), while the G488L mutant exhibited, respectively, 800- and 50-fold decreases in FAD binding and catalytic activity. Enzymic activity of each of these mutants could be restored by addition of FAD. Kinetic properties and the FMN content of these mutants were not affected by these substitutions, with the exception of a 3-fold increase in Y456S K(m)(cyt )(c) and a 70% decrease in R454E FMN content, suggesting that the FMN- and FAD-binding domains are largely, but not completely, independent. Even though Trp(677) is stacked against the re-face of FAD, suggesting an important role in FAD binding, deletion of both Trp(677) and the carboxyl-terminal Ser(678) decreased catalytic activity 50-fold without affecting FAD content.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022049     DOI: 10.1074/jbc.M008380200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.

Authors:  Xiu Jun Wang; Mark Chamberlain; Olga Vassieva; Colin J Henderson; C Roland Wolf
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

2.  Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.

Authors:  Chuanwu Xia; Djemel Hamdane; Anna L Shen; Vivian Choi; Charles B Kasper; Naw May Pearl; Haoming Zhang; Sang-Choul Im; Lucy Waskell; Jung-Ja P Kim
Journal:  J Biol Chem       Date:  2011-02-23       Impact factor: 5.157

3.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Authors:  Ningwu Huang; Amit V Pandey; Vishal Agrawal; William Reardon; Pablo D Lapunzina; David Mowat; Ethylin Wang Jabs; Guy Van Vliet; Joseph Sack; Christa E Flück; Walter L Miller
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

4.  Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer.

Authors:  Chuanwu Xia; Freeborn Rwere; Sangchoul Im; Anna L Shen; Lucy Waskell; Jung-Ja P Kim
Journal:  Biochemistry       Date:  2018-01-30       Impact factor: 3.162

5.  Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency.

Authors:  Chuanwu Xia; Satya P Panda; Christopher C Marohnic; Pavel Martásek; Bettie Sue Masters; Jung-Ja P Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

6.  Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats.

Authors:  Su-Young Choi; Liam Fischer; Kyunghee Yang; Hyejin Chung; Hyunyoung Jeong
Journal:  Biochem Pharmacol       Date:  2011-01-08       Impact factor: 5.858

7.  Pseudomonad cyclopentadecanone monooxygenase displaying an uncommon spectrum of Baeyer-Villiger oxidations of cyclic ketones.

Authors:  Hiroaki Iwaki; Shaozhao Wang; Stephan Grosse; Hélène Bergeron; Ayako Nagahashi; Jittiwud Lertvorachon; Jianzhong Yang; Yasuo Konishi; Yoshie Hasegawa; Peter C K Lau
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

8.  Understanding uncoupling in the multiredox centre P450 3A4-BMR model system.

Authors:  Danilo Degregorio; Sheila J Sadeghi; Giovanna Di Nardo; Gianfranco Gilardi; Sandro P Solinas
Journal:  J Biol Inorg Chem       Date:  2010-09-21       Impact factor: 3.358

9.  Hepatocyte circadian clock controls acetaminophen bioactivation through NADPH-cytochrome P450 oxidoreductase.

Authors:  Brian P Johnson; Jacqueline A Walisser; Yan Liu; Anna L Shen; Erin L McDearmon; Susan M Moran; Brian E McIntosh; Aaron L Vollrath; Andrew C Schook; Joseph S Takahashi; Christopher A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

10.  Structural and Functional Studies of the Membrane-Binding Domain of NADPH-Cytochrome P450 Oxidoreductase.

Authors:  Chuanwu Xia; Anna L Shen; Panida Duangkaew; Rattanawadee Kotewong; Pornpimol Rongnoparut; Jimmy Feix; Jung-Ja P Kim
Journal:  Biochemistry       Date:  2019-05-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.